Impact: Supporting Patients Through Grants
Although great progress has been made in the treatment and care of breast cancer patients, there is still more work to be done. Our Global Medical Grant programs support independent research, quality improvement, and education initiatives that fill evidence gaps, improve quality of care, and provide independent medical and patient education initiatives around the world. Pfizer has awarded nearly $200M in global medical grants for breast cancer to date.
These grants, administered through Conquer Cancer’s EveryGrant® solution, are part of the Pfizer Global Medical Grants program Equitable Care of Metastatic Breast Cancer (mBC) Patients: A Phased Approach to Understanding and Addressing Healthcare Disparities for People of Color.

Conquer Cancer®, the ASCO Foundation, funds research for every cancer, every patient, everywhere. Since 1984, its Grants & Awards program has awarded more than $158 million through more than 2,600 grants and awards to improve cancer care and accelerate breakthroughs in clinical and translational oncology research. Conquer Cancer’s EveryGrant® program is an end-to-end, white label solution, helping organizations develop and deliver grants programs that attract the brightest researchers and make a difference for people with cancer everywhere. For more information, visit CONQUER.ORG.